Loffredo John T, Friedrich Thomas C, León Enrique J, Stephany Jason J, Rodrigues Denise S, Spencer Sean P, Bean Alex T, Beal Dominic R, Burwitz Benjamin J, Rudersdorf Richard A, Wallace Lyle T, Piaskowski Shari M, May Gemma E, Sidney John, Gostick Emma, Wilson Nancy A, Price David A, Kallas Esper G, Piontkivska Helen, Hughes Austin L, Sette Alessandro, Watkins David I
Wisconsin National Primate Research Center (WNPRC), University of Wisconsin-Madison, Madison, Wisconsin, United States of America.
PLoS One. 2007 Nov 14;2(11):e1152. doi: 10.1371/journal.pone.0001152.
It is generally accepted that CD8+ T cell responses play an important role in control of immunodeficiency virus replication. The association of HLA-B27 and -B57 with control of viremia supports this conclusion. However, specific correlates of viral control in individuals expressing these alleles have been difficult to define. We recently reported that transient in vivo CD8+ cell depletion in simian immunodeficiency virus (SIV)-infected elite controller (EC) macaques resulted in a brief period of viral recrudescence. SIV replication was rapidly controlled with the reappearance of CD8+ cells, implicating that these cells actively suppress viral replication in ECs.
Here we show that three ECs in that study made at least seven robust CD8+ T cell responses directed against novel epitopes in Vif, Rev, and Nef restricted by the MHC class I molecule Mamu-B08. Two of these Mamu-B08-positive animals subsequently lost control of SIV replication. Their breakthrough virus harbored substitutions in multiple Mamu-B08-restricted epitopes. Indeed, we found evidence for selection pressure mediated by Mamu-B08-restricted CD8+ T cells in all of the newly identified epitopes in a cohort of chronically infected macaques.
Together, our data suggest that Mamu-B08-restricted CD8+ T cell responses effectively control replication of pathogenic SIV(mac)239. All seven regions encoding Mamu-B08-restricted CD8+ T cell epitopes also exhibit amino acid replacements typically seen only in the presence of Mamu-B08, suggesting that the variation we observe is indeed selected by CD8+ T cell responses. SIV(mac)239 infection of Indian rhesus macaques expressing Mamu-B08 may therefore provide an animal model for understanding CD8+ T cell-mediated control of HIV replication in humans.
普遍认为CD8 + T细胞反应在免疫缺陷病毒复制的控制中起重要作用。HLA - B27和 - B57与病毒血症控制的关联支持了这一结论。然而,表达这些等位基因的个体中病毒控制的具体相关因素一直难以确定。我们最近报道,在感染猿猴免疫缺陷病毒(SIV)的精英控制者(EC)猕猴体内短暂清除CD8 +细胞会导致病毒短暂复发。随着CD8 +细胞的重新出现,SIV复制迅速得到控制,这表明这些细胞在EC中积极抑制病毒复制。
在此我们表明,该研究中的三名EC至少产生了七种针对Vif、Rev和Nef中新表位的强大CD8 + T细胞反应,这些表位受MHC I类分子Mamu - B08限制。其中两只Mamu - B08阳性动物随后失去了对SIV复制的控制。它们突破的病毒在多个Mamu - B08限制的表位中存在替换。事实上,我们在一组慢性感染猕猴的所有新鉴定表位中发现了由Mamu - B08限制的CD8 + T细胞介导的选择压力的证据。
总之,我们的数据表明,Mamu - B08限制的CD8 + T细胞反应有效控制致病性SIV(mac)239的复制。编码Mamu - B08限制的CD8 + T细胞表位的所有七个区域也表现出通常仅在存在Mamu - B08时才出现的氨基酸替换,这表明我们观察到的变异确实是由CD8 + T细胞反应选择的。因此,表达Mamu - B08的印度恒河猴感染SIV(mac)239可能为理解人类中CD8 + T细胞介导的HIV复制控制提供一个动物模型。